Oralair licence transforms Stallergenes
This article was originally published in Scrip
Executive Summary
Marketing approval for Stallergenes' Oralair Grasses (sublingual desensitisation tablets) from Germany's Paul Ehrlich Institute has propelled the company into a different universe, says Dr Louis Champion, managing director.